- Home
- OCX vs RPID Comparison
OCX vs RPID Comparison
Compare OCX & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCX
- RPID
- Stock Information
- Founded
- OCX 2009
- RPID 2006
- Country
- OCX United States
- RPID United States
- Employees
- OCX N/A
- RPID N/A
- Industry
- OCX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- RPID Medical Specialities
- Sector
- OCX Health Care
- RPID Health Care
- Exchange
- OCX Nasdaq
- RPID Nasdaq
- Market Cap
- OCX 38.7M
- RPID 37.3M
- IPO Year
- OCX N/A
- RPID 2021
- Fundamental
- Price
- OCX $2.61
- RPID $1.04
- Analyst Decision
- OCX Buy
- RPID
- Analyst Count
- OCX 3
- RPID 0
- Target Price
- OCX $4.42
- RPID N/A
- AVG Volume (30 Days)
- OCX 64.0K
- RPID 128.8K
- Earning Date
- OCX 11-12-2024
- RPID 11-01-2024
- Dividend Yield
- OCX N/A
- RPID N/A
- EPS Growth
- OCX N/A
- RPID N/A
- EPS
- OCX N/A
- RPID N/A
- Revenue
- OCX $709,000.00
- RPID $26,170,000.00
- Revenue This Year
- OCX N/A
- RPID $24.34
- Revenue Next Year
- OCX $167.93
- RPID $19.49
- P/E Ratio
- OCX N/A
- RPID N/A
- Revenue Growth
- OCX N/A
- RPID 27.31
- 52 Week Low
- OCX $2.29
- RPID $0.58
- 52 Week High
- OCX $4.34
- RPID $1.34
- Technical
- Relative Strength Index (RSI)
- OCX 30.23
- RPID 48.03
- Support Level
- OCX $2.73
- RPID $1.16
- Resistance Level
- OCX $3.04
- RPID $1.30
- Average True Range (ATR)
- OCX 0.14
- RPID 0.11
- MACD
- OCX -0.03
- RPID -0.01
- Stochastic Oscillator
- OCX 0.00
- RPID 3.23
About OCX Oncocyte Corporation
OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers.
About RPID Rapid Micro Biosystems Inc.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.